Uy Ear Score: 41
Analyst at
Mizuho Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-2.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
50%
8 W / 8 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
63%
5 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
38%
3 W / 5 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
13%
1 W / 7 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
53%
8 W / 7 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
50%
8 W / 8 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 |
uniQure N.V.
QURE
|
BUY |
$68.00
Est. +39%
|
$48.85 | $51.72 |
Pending
|
$38.23
-21.7%
|
| Mar 13, 2026 |
Relmada Therapeutics Inc
RLMD
|
BUY |
$10.00
Est. +69%
|
$5.91 | $8.00 |
Pending
|
$3.83
-35.2%
|
| Mar 12, 2026 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$31.00
Est. +82%
|
$17.04 | $23.85 |
Pending
|
$18.67
+9.6%
|
| Feb 04, 2026 |
Evolus Inc
EOLS
|
BUY |
$15.00
Est. +219%
|
$4.70 | $9.31 |
Pending
|
$7.97
+69.6%
|
| Dec 08, 2025 |
uniQure N.V.
QURE
|
BUY |
$33.00
Est. +52%
|
$21.77 | $51.72 |
Target Met
|
$38.23
+75.6%
|
| Nov 28, 2025 |
Arcutis Biotherapeutics Inc
ARQT
|
BUY |
$37.00
Est. +20%
|
$30.96 | $31.77 |
Pending
|
$26.92
-13.0%
|
| Nov 05, 2025 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$26.00
Est. +60%
|
$16.20 | $24.68 |
Pending
|
$18.67
+15.2%
|
| Oct 29, 2025 |
Arcutis Biotherapeutics Inc
ARQT
|
BUY |
$32.00
Est. +28%
|
$24.95 | $31.77 |
Bullseye Hit (±1%)
|
$26.92
+7.9%
|
| Sep 25, 2025 |
uniQure N.V.
QURE
|
BUY |
$60.00
Est. +25%
|
$48.09 | $71.50 |
Target Met
|
$38.23
-20.5%
|
| Jun 24, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$200.00
Est. +21%
|
$165.13 | $155.95 |
Miss
|
$18.67
-88.7%
|
| May 24, 2024 |
Cartesian Therapeutics Inc
RNAC
|
BUY |
$40.00
Est. +57%
|
$25.46 | $26.50 |
Miss
|
$7.41
-70.9%
|
| May 17, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$179.00
Est. +35%
|
$132.74 | $155.95 |
Miss
|
$18.67
-85.9%
|
| May 15, 2024 |
Arcutis Biotherapeutics Inc
ARQT
|
BUY |
$18.00
Est. +121%
|
$8.13 | $17.75 |
Precision Hit (±3%)
|
$26.92
+231.1%
|
| May 09, 2024 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$21.00
Est. +23%
|
$17.13 | $20.67 |
Precision Hit (±3%)
|
$20.68
+20.7%
|
| Aug 23, 2022 |
Ocugen Inc
OCGN
|
BUY |
$5.00
Est. +114%
|
$2.34 | - | - |
$1.02
-56.4%
|
| Jan 10, 2022 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$160.00
Est. +110%
|
$76.15 | - | - |
$18.67
-75.5%
|
uniQure N.V.
QURE
Jun 25, 2026
Signal & Target
BUY
$68.00
Start Price
$48.85
Best Price (1Y)
$51.72
Current Price
$38.23
Return
-21.7%
Relmada Therapeutics Inc
RLMD
Mar 13, 2026
Signal & Target
BUY
$10.00
Start Price
$5.91
Best Price (1Y)
$8.00
Current Price
$3.83
Return
-35.2%
Sarepta Therapeutics Inc
SRPT
Mar 12, 2026
Signal & Target
BUY
$31.00
Start Price
$17.04
Best Price (1Y)
$23.85
Current Price
$18.67
Return
+9.6%
Evolus Inc
EOLS
Feb 04, 2026
Signal & Target
BUY
$15.00
Start Price
$4.70
Best Price (1Y)
$9.31
Current Price
$7.97
Return
+69.6%
uniQure N.V.
QURE
Dec 08, 2025
Signal & Target
BUY
$33.00
Start Price
$21.77
Best Price (1Y)
$51.72
Current Price
$38.23
Return
+75.6%
Arcutis Biotherapeutics Inc
ARQT
Nov 28, 2025
Signal & Target
BUY
$37.00
Start Price
$30.96
Best Price (1Y)
$31.77
Current Price
$26.92
Return
-13.0%
Sarepta Therapeutics Inc
SRPT
Nov 05, 2025
Signal & Target
BUY
$26.00
Start Price
$16.20
Best Price (1Y)
$24.68
Current Price
$18.67
Return
+15.2%
Arcutis Biotherapeutics Inc
ARQT
Oct 29, 2025
Signal & Target
BUY
$32.00
Start Price
$24.95
Best Price (1Y)
$31.77
Current Price
$26.92
Return
+7.9%
uniQure N.V.
QURE
Sep 25, 2025
Signal & Target
BUY
$60.00
Start Price
$48.09
Best Price (1Y)
$71.50
Current Price
$38.23
Return
-20.5%
Sarepta Therapeutics Inc
SRPT
Jun 24, 2024
Signal & Target
BUY
$200.00
Start Price
$165.13
Best Price (1Y)
$155.95
Current Price
$18.67
Return
-88.7%
Cartesian Therapeutics Inc
RNAC
May 24, 2024
Signal & Target
BUY
$40.00
Start Price
$25.46
Best Price (1Y)
$26.50
Current Price
$7.41
Return
-70.9%
Sarepta Therapeutics Inc
SRPT
May 17, 2024
Signal & Target
BUY
$179.00
Start Price
$132.74
Best Price (1Y)
$155.95
Current Price
$18.67
Return
-85.9%
Arcutis Biotherapeutics Inc
ARQT
May 15, 2024
Signal & Target
BUY
$18.00
Start Price
$8.13
Best Price (1Y)
$17.75
Current Price
$26.92
Return
+231.1%
Acadia Pharmaceuticals Inc
ACAD
May 09, 2024
Signal & Target
BUY
$21.00
Start Price
$17.13
Best Price (1Y)
$20.67
Current Price
$20.68
Return
+20.7%
Ocugen Inc
OCGN
Aug 23, 2022
Signal & Target
BUY
$5.00
Start Price
$2.34
Best Price (1Y)
-
Current Price
$1.02
Return
-56.4%
Sarepta Therapeutics Inc
SRPT
Jan 10, 2022
Signal & Target
BUY
$160.00
Start Price
$76.15
Best Price (1Y)
-
Current Price
$18.67
Return
-75.5%